Literature DB >> 16359237

DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.

Gabriela Mellado-Sánchez1, Julio García-Cordero, Rosendo Luria-Pérez, Lucero Lázaro-Olan, Leopoldo Santos-Argumedo, Benito Gutiérrez-Castañeda, Iris Estrada-García, Leticia Cedillo-Barrón.   

Abstract

DNA priming-protein boosting is a strategy used to establish strong immunity to a specific pathogen by the use of two different antigens through sequential delivery systems. In this work, two recombinant plasmids were used, one encoding for the dengue virus E protein, which is know to induce neutralizing antibodies (pcDNA 3.1/E), and the other encoding for the Dengue virus nonstructural protein 1 (pcDNA 3.1/NS1), as a source of B- and T-cell epitopes possibly involved in protective immunity. We showed that immunization of BALB/c mice with three priming doses of both plasmids pcDNA 3.1/E and/or pcDNA 3.1/NS1 were able to induce antibody responses to E protein with a single plasmid; in contrast to the antibody response to NS1 protein we observed an additive effect in terms of antibody response. Moreover, using a prime-boost protocol in which both plasmid constructs were co-administrated followed by a boost of homologous GST-E and GST-NS1 recombinant proteins, we observed an increased antibody response to NS1 and to E protein compared to animals vaccinated with the proteins or with dengue constructs alone. If neutralizing antibodies play an important role in dengue infection, antibodies generated with this regimen was also significantly better than the administration of the mix of proteins alone. These results suggest that NS1 and E proteins together could be considered in a design of subunit recombinant vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359237     DOI: 10.1089/vim.2005.18.709

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  10 in total

1.  Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.

Authors:  Venkatramana D Krishna; Manjuladevi Rangappa; Vijaya Satchidanandam
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

2.  Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells.

Authors:  Kyung Min Chung; Bruce S Thompson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

Review 3.  Animal models of dengue virus infection.

Authors:  Simona Zompi; Eva Harris
Journal:  Viruses       Date:  2012-01-09       Impact factor: 5.048

Review 4.  Mouse models to study dengue virus immunology and pathogenesis.

Authors:  Raphaël M Zellweger; Sujan Shresta
Journal:  Front Immunol       Date:  2014-04-10       Impact factor: 7.561

5.  Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice.

Authors:  Kaihao Feng; Xiaoyan Zheng; Ran Wang; Na Gao; Dongying Fan; Ziyang Sheng; Hongning Zhou; Hui Chen; Jing An
Journal:  Front Cell Infect Microbiol       Date:  2020-03-17       Impact factor: 5.293

6.  Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.

Authors:  Mayra R Montecillo-Aguado; Alfredo E Montes-Gómez; Julio García-Cordero; Josselin Corzo-Gómez; Héctor Vivanco-Cid; Gabriela Mellado-Sánchez; J Esteban Muñoz-Medina; Benito Gutiérrez-Castañeda; Leopoldo Santos-Argumedo; César González-Bonilla; Leticia Cedillo-Barrón
Journal:  J Immunol Res       Date:  2019-09-02       Impact factor: 4.818

Review 7.  'Mix and Match' vaccination: Is dengue next?

Authors:  Camila D Odio; Leah C Katzelnick
Journal:  Vaccine       Date:  2022-10-01       Impact factor: 4.169

Review 8.  Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?

Authors:  Iris Valdés; Laura Lazo; Lisset Hermida; Gerardo Guillén; Lázaro Gil
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

Review 9.  Humanized Mice in Dengue Research: A Comparison with Other Mouse Models.

Authors:  Carolina Coronel-Ruiz; Hernando Gutiérrez-Barbosa; Sandra Medina-Moreno; Myriam L Velandia-Romero; Joel V Chua; Jaime E Castellanos; Juan C Zapata
Journal:  Vaccines (Basel)       Date:  2020-01-22

Review 10.  Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge?

Authors:  Ada Maria Barcelos Alves; Simone Morais Costa; Paolla Beatriz Almeida Pinto
Journal:  Front Med Technol       Date:  2021-04-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.